231 related articles for article (PubMed ID: 16801426)
1. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
[TBL] [Abstract][Full Text] [Related]
2. Effect of severity of sepsis on tissue concentrations of linezolid.
Thallinger C; Buerger C; Plock N; Kljucar S; Wuenscher S; Sauermann R; Kloft C; Joukhadar C
J Antimicrob Chemother; 2008 Jan; 61(1):173-6. PubMed ID: 17999976
[TBL] [Abstract][Full Text] [Related]
3. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
4. The effect of food on plasma and tissue concentrations of linezolid after multiple doses.
Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C
Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930
[TBL] [Abstract][Full Text] [Related]
5. Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
Minichmayr IK; Schaeftlein A; Kuti JL; Zeitlinger M; Kloft C
Clin Pharmacokinet; 2017 Jun; 56(6):617-633. PubMed ID: 27753002
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
[TBL] [Abstract][Full Text] [Related]
7. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
[TBL] [Abstract][Full Text] [Related]
8. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
[TBL] [Abstract][Full Text] [Related]
9. Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
Wiskirchen DE; Shepard A; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2011 Sep; 55(9):4170-5. PubMed ID: 21709078
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Toutain J; Chassard D; Saux MC; Allaouchiche B
Crit Care Med; 2005 Jul; 33(7):1529-33. PubMed ID: 16003058
[TBL] [Abstract][Full Text] [Related]
11. Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration.
De Pascale G; Fortuna S; Tumbarello M; Cutuli SL; Vallecoccia M; Spanu T; Bello G; Montini L; Pennisi MA; Navarra P; Antonelli M
Intensive Care Med; 2015 Jan; 41(1):103-10. PubMed ID: 25413377
[TBL] [Abstract][Full Text] [Related]
12. Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.
Dehghanyar P; Bürger C; Zeitlinger M; Islinger F; Kovar F; Müller M; Kloft C; Joukhadar C
Antimicrob Agents Chemother; 2005 Jun; 49(6):2367-71. PubMed ID: 15917535
[TBL] [Abstract][Full Text] [Related]
13. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y
Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918
[TBL] [Abstract][Full Text] [Related]
15. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections.
Traunmüller F; Schintler MV; Spendel S; Popovic M; Mauric O; Scharnagl E; Joukhadar C
Int J Antimicrob Agents; 2010 Jul; 36(1):84-6. PubMed ID: 20456925
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
17. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
Burkhardt O; Brunner M; Schmidt S; Grant M; Tang Y; Derendorf H
J Antimicrob Chemother; 2006 Sep; 58(3):632-6. PubMed ID: 16840426
[TBL] [Abstract][Full Text] [Related]
18. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
Eslam RB; Burian A; Vila G; Sauermann R; Hammer A; Frenzel D; Minichmayr IK; Kloft C; Matzneller P; Oesterreicher Z; Zeitlinger M
J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
[TBL] [Abstract][Full Text] [Related]
19. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Caillault-Sergent A; Djabarouti S; Guillaume C; Xuereb F; Bouvet L; Rimmelé T; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2012 May; 67(5):1207-10. PubMed ID: 22351682
[TBL] [Abstract][Full Text] [Related]
20. Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers.
Sahre M; Sabarinath S; Grant M; Seubert C; Deanda C; Prokocimer P; Derendorf H
Int J Antimicrob Agents; 2012 Jul; 40(1):51-4. PubMed ID: 22584101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]